nodes	percent_of_prediction	percent_of_DWPC	metapath
Brinzolamide—CYP3A4—Methylprednisolone—psoriatic arthritis	0.00489	0.248	CbGbCtD
Brinzolamide—CYP3A4—Triamcinolone—psoriatic arthritis	0.00371	0.188	CbGbCtD
Brinzolamide—CYP3A4—Betamethasone—psoriatic arthritis	0.00318	0.161	CbGbCtD
Brinzolamide—CYP3A4—Prednisolone—psoriatic arthritis	0.00314	0.159	CbGbCtD
Brinzolamide—CYP3A4—Prednisone—psoriatic arthritis	0.00297	0.15	CbGbCtD
Brinzolamide—CYP3A4—Dexamethasone—psoriatic arthritis	0.00185	0.0937	CbGbCtD
Brinzolamide—Erythema—Methylprednisolone—psoriatic arthritis	0.00178	0.00182	CcSEcCtD
Brinzolamide—Malnutrition—Methylprednisolone—psoriatic arthritis	0.00178	0.00182	CcSEcCtD
Brinzolamide—Breast disorder—Methotrexate—psoriatic arthritis	0.00177	0.0018	CcSEcCtD
Brinzolamide—Malaise—Prednisolone—psoriatic arthritis	0.00175	0.00179	CcSEcCtD
Brinzolamide—Dysgeusia—Triamcinolone—psoriatic arthritis	0.00175	0.00178	CcSEcCtD
Brinzolamide—Vertigo—Prednisolone—psoriatic arthritis	0.00174	0.00178	CcSEcCtD
Brinzolamide—Eye disorder—Betamethasone—psoriatic arthritis	0.00174	0.00177	CcSEcCtD
Brinzolamide—Eye disorder—Dexamethasone—psoriatic arthritis	0.00174	0.00177	CcSEcCtD
Brinzolamide—Back pain—Triamcinolone—psoriatic arthritis	0.00173	0.00176	CcSEcCtD
Brinzolamide—Asthma—Methotrexate—psoriatic arthritis	0.00169	0.00173	CcSEcCtD
Brinzolamide—Angiopathy—Dexamethasone—psoriatic arthritis	0.00169	0.00172	CcSEcCtD
Brinzolamide—Angiopathy—Betamethasone—psoriatic arthritis	0.00169	0.00172	CcSEcCtD
Brinzolamide—Hypertension—Prednisolone—psoriatic arthritis	0.00168	0.00171	CcSEcCtD
Brinzolamide—Arrhythmia—Dexamethasone—psoriatic arthritis	0.00166	0.0017	CcSEcCtD
Brinzolamide—Arrhythmia—Betamethasone—psoriatic arthritis	0.00166	0.0017	CcSEcCtD
Brinzolamide—Ill-defined disorder—Triamcinolone—psoriatic arthritis	0.00166	0.00169	CcSEcCtD
Brinzolamide—Ill-defined disorder—Methylprednisolone—psoriatic arthritis	0.00165	0.00169	CcSEcCtD
Brinzolamide—Bradycardia—Prednisone—psoriatic arthritis	0.00165	0.00168	CcSEcCtD
Brinzolamide—Alopecia—Betamethasone—psoriatic arthritis	0.00164	0.00168	CcSEcCtD
Brinzolamide—Alopecia—Dexamethasone—psoriatic arthritis	0.00164	0.00168	CcSEcCtD
Brinzolamide—Discomfort—Prednisolone—psoriatic arthritis	0.00163	0.00167	CcSEcCtD
Brinzolamide—Abdominal discomfort—Methotrexate—psoriatic arthritis	0.00162	0.00165	CcSEcCtD
Brinzolamide—Erythema—Betamethasone—psoriatic arthritis	0.00162	0.00165	CcSEcCtD
Brinzolamide—Erythema—Dexamethasone—psoriatic arthritis	0.00162	0.00165	CcSEcCtD
Brinzolamide—Malaise—Triamcinolone—psoriatic arthritis	0.00161	0.00164	CcSEcCtD
Brinzolamide—Malaise—Methylprednisolone—psoriatic arthritis	0.00161	0.00164	CcSEcCtD
Brinzolamide—Vertigo—Triamcinolone—psoriatic arthritis	0.0016	0.00164	CcSEcCtD
Brinzolamide—Vertigo—Methylprednisolone—psoriatic arthritis	0.0016	0.00163	CcSEcCtD
Brinzolamide—Connective tissue disorder—Prednisone—psoriatic arthritis	0.00159	0.00162	CcSEcCtD
Brinzolamide—Erectile dysfunction—Methotrexate—psoriatic arthritis	0.00156	0.00159	CcSEcCtD
Brinzolamide—Cough—Triamcinolone—psoriatic arthritis	0.00156	0.00159	CcSEcCtD
Brinzolamide—Tachycardia—Prednisolone—psoriatic arthritis	0.00155	0.00158	CcSEcCtD
Brinzolamide—Hypertension—Triamcinolone—psoriatic arthritis	0.00154	0.00157	CcSEcCtD
Brinzolamide—Hypertension—Methylprednisolone—psoriatic arthritis	0.00154	0.00157	CcSEcCtD
Brinzolamide—Myalgia—Triamcinolone—psoriatic arthritis	0.00152	0.00155	CcSEcCtD
Brinzolamide—Myalgia—Methylprednisolone—psoriatic arthritis	0.00152	0.00155	CcSEcCtD
Brinzolamide—Arthralgia—Methylprednisolone—psoriatic arthritis	0.00152	0.00155	CcSEcCtD
Brinzolamide—Eye disorder—Prednisone—psoriatic arthritis	0.00151	0.00155	CcSEcCtD
Brinzolamide—Infestation—Methotrexate—psoriatic arthritis	0.00151	0.00154	CcSEcCtD
Brinzolamide—Infestation NOS—Methotrexate—psoriatic arthritis	0.00151	0.00154	CcSEcCtD
Brinzolamide—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.00151	0.00154	CcSEcCtD
Brinzolamide—Depression—Methotrexate—psoriatic arthritis	0.0015	0.00153	CcSEcCtD
Brinzolamide—Ill-defined disorder—Dexamethasone—psoriatic arthritis	0.0015	0.00153	CcSEcCtD
Brinzolamide—Ill-defined disorder—Betamethasone—psoriatic arthritis	0.0015	0.00153	CcSEcCtD
Brinzolamide—Discomfort—Triamcinolone—psoriatic arthritis	0.0015	0.00153	CcSEcCtD
Brinzolamide—Discomfort—Methylprednisolone—psoriatic arthritis	0.0015	0.00153	CcSEcCtD
Brinzolamide—Dry mouth—Triamcinolone—psoriatic arthritis	0.00149	0.00152	CcSEcCtD
Brinzolamide—Angiopathy—Prednisone—psoriatic arthritis	0.00147	0.0015	CcSEcCtD
Brinzolamide—Conjunctivitis—Methotrexate—psoriatic arthritis	0.00147	0.0015	CcSEcCtD
Brinzolamide—Immune system disorder—Prednisone—psoriatic arthritis	0.00146	0.00149	CcSEcCtD
Brinzolamide—Malaise—Dexamethasone—psoriatic arthritis	0.00146	0.00149	CcSEcCtD
Brinzolamide—Malaise—Betamethasone—psoriatic arthritis	0.00146	0.00149	CcSEcCtD
Brinzolamide—Vertigo—Dexamethasone—psoriatic arthritis	0.00146	0.00148	CcSEcCtD
Brinzolamide—Vertigo—Betamethasone—psoriatic arthritis	0.00146	0.00148	CcSEcCtD
Brinzolamide—Arrhythmia—Prednisone—psoriatic arthritis	0.00145	0.00148	CcSEcCtD
Brinzolamide—Infection—Triamcinolone—psoriatic arthritis	0.00145	0.00148	CcSEcCtD
Brinzolamide—Infection—Methylprednisolone—psoriatic arthritis	0.00144	0.00147	CcSEcCtD
Brinzolamide—Insomnia—Prednisolone—psoriatic arthritis	0.00143	0.00146	CcSEcCtD
Brinzolamide—Alopecia—Prednisone—psoriatic arthritis	0.00143	0.00146	CcSEcCtD
Brinzolamide—Hepatobiliary disease—Methotrexate—psoriatic arthritis	0.00143	0.00146	CcSEcCtD
Brinzolamide—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.00143	0.00145	CcSEcCtD
Brinzolamide—Epistaxis—Methotrexate—psoriatic arthritis	0.00142	0.00145	CcSEcCtD
Brinzolamide—Paraesthesia—Prednisolone—psoriatic arthritis	0.00142	0.00145	CcSEcCtD
Brinzolamide—Tachycardia—Triamcinolone—psoriatic arthritis	0.00142	0.00145	CcSEcCtD
Brinzolamide—Mental disorder—Prednisone—psoriatic arthritis	0.00142	0.00145	CcSEcCtD
Brinzolamide—Tachycardia—Methylprednisolone—psoriatic arthritis	0.00142	0.00145	CcSEcCtD
Brinzolamide—Skin disorder—Methylprednisolone—psoriatic arthritis	0.00141	0.00144	CcSEcCtD
Brinzolamide—Malnutrition—Prednisone—psoriatic arthritis	0.00141	0.00144	CcSEcCtD
Brinzolamide—Erythema—Prednisone—psoriatic arthritis	0.00141	0.00144	CcSEcCtD
Brinzolamide—Hypertension—Betamethasone—psoriatic arthritis	0.0014	0.00143	CcSEcCtD
Brinzolamide—Hypertension—Dexamethasone—psoriatic arthritis	0.0014	0.00143	CcSEcCtD
Brinzolamide—Myalgia—Dexamethasone—psoriatic arthritis	0.00138	0.00141	CcSEcCtD
Brinzolamide—Myalgia—Betamethasone—psoriatic arthritis	0.00138	0.00141	CcSEcCtD
Brinzolamide—Discomfort—Dexamethasone—psoriatic arthritis	0.00136	0.00139	CcSEcCtD
Brinzolamide—Discomfort—Betamethasone—psoriatic arthritis	0.00136	0.00139	CcSEcCtD
Brinzolamide—Hypotension—Methylprednisolone—psoriatic arthritis	0.00136	0.00139	CcSEcCtD
Brinzolamide—Pain—Prednisolone—psoriatic arthritis	0.00136	0.00138	CcSEcCtD
Brinzolamide—Pharyngitis—Methotrexate—psoriatic arthritis	0.00134	0.00137	CcSEcCtD
Brinzolamide—Urinary tract disorder—Methotrexate—psoriatic arthritis	0.00134	0.00136	CcSEcCtD
Brinzolamide—Vision blurred—Prednisone—psoriatic arthritis	0.00133	0.00136	CcSEcCtD
Brinzolamide—Urethral disorder—Methotrexate—psoriatic arthritis	0.00133	0.00135	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.00133	0.00135	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.00132	0.00135	CcSEcCtD
Brinzolamide—Insomnia—Triamcinolone—psoriatic arthritis	0.00132	0.00134	CcSEcCtD
Brinzolamide—Insomnia—Methylprednisolone—psoriatic arthritis	0.00132	0.00134	CcSEcCtD
Brinzolamide—Infection—Dexamethasone—psoriatic arthritis	0.00131	0.00134	CcSEcCtD
Brinzolamide—Infection—Betamethasone—psoriatic arthritis	0.00131	0.00134	CcSEcCtD
Brinzolamide—Ill-defined disorder—Prednisone—psoriatic arthritis	0.00131	0.00134	CcSEcCtD
Brinzolamide—Paraesthesia—Triamcinolone—psoriatic arthritis	0.00131	0.00133	CcSEcCtD
Brinzolamide—Feeling abnormal—Prednisolone—psoriatic arthritis	0.00131	0.00133	CcSEcCtD
Brinzolamide—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.00131	0.00133	CcSEcCtD
Brinzolamide—Visual impairment—Methotrexate—psoriatic arthritis	0.00131	0.00133	CcSEcCtD
Brinzolamide—Dyspnoea—Triamcinolone—psoriatic arthritis	0.0013	0.00133	CcSEcCtD
Brinzolamide—Nervous system disorder—Betamethasone—psoriatic arthritis	0.0013	0.00132	CcSEcCtD
Brinzolamide—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.0013	0.00132	CcSEcCtD
Brinzolamide—Agitation—Prednisone—psoriatic arthritis	0.0013	0.00132	CcSEcCtD
Brinzolamide—Tachycardia—Dexamethasone—psoriatic arthritis	0.00129	0.00132	CcSEcCtD
Brinzolamide—Tachycardia—Betamethasone—psoriatic arthritis	0.00129	0.00132	CcSEcCtD
Brinzolamide—Dyspepsia—Triamcinolone—psoriatic arthritis	0.00128	0.00131	CcSEcCtD
Brinzolamide—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.00128	0.00131	CcSEcCtD
Brinzolamide—Malaise—Prednisone—psoriatic arthritis	0.00127	0.0013	CcSEcCtD
Brinzolamide—Vertigo—Prednisone—psoriatic arthritis	0.00127	0.00129	CcSEcCtD
Brinzolamide—Eye disorder—Methotrexate—psoriatic arthritis	0.00127	0.00129	CcSEcCtD
Brinzolamide—Tinnitus—Methotrexate—psoriatic arthritis	0.00126	0.00129	CcSEcCtD
Brinzolamide—Urticaria—Prednisolone—psoriatic arthritis	0.00126	0.00128	CcSEcCtD
Brinzolamide—Cardiac disorder—Methotrexate—psoriatic arthritis	0.00126	0.00128	CcSEcCtD
Brinzolamide—Fatigue—Triamcinolone—psoriatic arthritis	0.00126	0.00128	CcSEcCtD
Brinzolamide—Fatigue—Methylprednisolone—psoriatic arthritis	0.00125	0.00128	CcSEcCtD
Brinzolamide—Pain—Triamcinolone—psoriatic arthritis	0.00125	0.00127	CcSEcCtD
Brinzolamide—Hypotension—Dexamethasone—psoriatic arthritis	0.00124	0.00126	CcSEcCtD
Brinzolamide—Hypotension—Betamethasone—psoriatic arthritis	0.00124	0.00126	CcSEcCtD
Brinzolamide—Angiopathy—Methotrexate—psoriatic arthritis	0.00123	0.00125	CcSEcCtD
Brinzolamide—Immune system disorder—Methotrexate—psoriatic arthritis	0.00122	0.00125	CcSEcCtD
Brinzolamide—Mediastinal disorder—Methotrexate—psoriatic arthritis	0.00122	0.00125	CcSEcCtD
Brinzolamide—Hypertension—Prednisone—psoriatic arthritis	0.00122	0.00124	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.0012	0.00123	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.0012	0.00123	CcSEcCtD
Brinzolamide—Myalgia—Prednisone—psoriatic arthritis	0.0012	0.00123	CcSEcCtD
Brinzolamide—Arthralgia—Prednisone—psoriatic arthritis	0.0012	0.00123	CcSEcCtD
Brinzolamide—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.0012	0.00122	CcSEcCtD
Brinzolamide—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.0012	0.00122	CcSEcCtD
Brinzolamide—Alopecia—Methotrexate—psoriatic arthritis	0.0012	0.00122	CcSEcCtD
Brinzolamide—Insomnia—Betamethasone—psoriatic arthritis	0.0012	0.00122	CcSEcCtD
Brinzolamide—Insomnia—Dexamethasone—psoriatic arthritis	0.0012	0.00122	CcSEcCtD
Brinzolamide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.00119	0.00122	CcSEcCtD
Brinzolamide—Paraesthesia—Betamethasone—psoriatic arthritis	0.00119	0.00121	CcSEcCtD
Brinzolamide—Paraesthesia—Dexamethasone—psoriatic arthritis	0.00119	0.00121	CcSEcCtD
Brinzolamide—Discomfort—Prednisone—psoriatic arthritis	0.00119	0.00121	CcSEcCtD
Brinzolamide—Mental disorder—Methotrexate—psoriatic arthritis	0.00119	0.00121	CcSEcCtD
Brinzolamide—Malnutrition—Methotrexate—psoriatic arthritis	0.00118	0.0012	CcSEcCtD
Brinzolamide—Erythema—Methotrexate—psoriatic arthritis	0.00118	0.0012	CcSEcCtD
Brinzolamide—Hypersensitivity—Prednisolone—psoriatic arthritis	0.00117	0.00119	CcSEcCtD
Brinzolamide—Dyspepsia—Betamethasone—psoriatic arthritis	0.00116	0.00119	CcSEcCtD
Brinzolamide—Dyspepsia—Dexamethasone—psoriatic arthritis	0.00116	0.00119	CcSEcCtD
Brinzolamide—Urticaria—Triamcinolone—psoriatic arthritis	0.00116	0.00118	CcSEcCtD
Brinzolamide—Urticaria—Methylprednisolone—psoriatic arthritis	0.00116	0.00118	CcSEcCtD
Brinzolamide—Dysgeusia—Methotrexate—psoriatic arthritis	0.00115	0.00118	CcSEcCtD
Brinzolamide—Decreased appetite—Betamethasone—psoriatic arthritis	0.00115	0.00117	CcSEcCtD
Brinzolamide—Decreased appetite—Dexamethasone—psoriatic arthritis	0.00115	0.00117	CcSEcCtD
Brinzolamide—Infection—Prednisone—psoriatic arthritis	0.00114	0.00117	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.00114	0.00116	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.00114	0.00116	CcSEcCtD
Brinzolamide—Back pain—Methotrexate—psoriatic arthritis	0.00114	0.00116	CcSEcCtD
Brinzolamide—Fatigue—Dexamethasone—psoriatic arthritis	0.00114	0.00116	CcSEcCtD
Brinzolamide—Fatigue—Betamethasone—psoriatic arthritis	0.00114	0.00116	CcSEcCtD
Brinzolamide—Pain—Dexamethasone—psoriatic arthritis	0.00113	0.00115	CcSEcCtD
Brinzolamide—Pain—Betamethasone—psoriatic arthritis	0.00113	0.00115	CcSEcCtD
Brinzolamide—Nervous system disorder—Prednisone—psoriatic arthritis	0.00113	0.00115	CcSEcCtD
Brinzolamide—Tachycardia—Prednisone—psoriatic arthritis	0.00112	0.00115	CcSEcCtD
Brinzolamide—Skin disorder—Prednisone—psoriatic arthritis	0.00112	0.00114	CcSEcCtD
Brinzolamide—Vision blurred—Methotrexate—psoriatic arthritis	0.00111	0.00113	CcSEcCtD
Brinzolamide—Ill-defined disorder—Methotrexate—psoriatic arthritis	0.00109	0.00112	CcSEcCtD
Brinzolamide—Feeling abnormal—Betamethasone—psoriatic arthritis	0.00109	0.00111	CcSEcCtD
Brinzolamide—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.00109	0.00111	CcSEcCtD
Brinzolamide—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.00107	0.0011	CcSEcCtD
Brinzolamide—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.00107	0.00109	CcSEcCtD
Brinzolamide—Malaise—Methotrexate—psoriatic arthritis	0.00106	0.00108	CcSEcCtD
Brinzolamide—Vertigo—Methotrexate—psoriatic arthritis	0.00106	0.00108	CcSEcCtD
Brinzolamide—Urticaria—Betamethasone—psoriatic arthritis	0.00105	0.00107	CcSEcCtD
Brinzolamide—Urticaria—Dexamethasone—psoriatic arthritis	0.00105	0.00107	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.00105	0.00107	CcSEcCtD
Brinzolamide—Dizziness—Prednisolone—psoriatic arthritis	0.00105	0.00107	CcSEcCtD
Brinzolamide—Asthenia—Triamcinolone—psoriatic arthritis	0.00105	0.00107	CcSEcCtD
Brinzolamide—Asthenia—Methylprednisolone—psoriatic arthritis	0.00104	0.00106	CcSEcCtD
Brinzolamide—Insomnia—Prednisone—psoriatic arthritis	0.00104	0.00106	CcSEcCtD
Brinzolamide—Paraesthesia—Prednisone—psoriatic arthritis	0.00103	0.00105	CcSEcCtD
Brinzolamide—Pruritus—Triamcinolone—psoriatic arthritis	0.00103	0.00105	CcSEcCtD
Brinzolamide—Cough—Methotrexate—psoriatic arthritis	0.00103	0.00105	CcSEcCtD
Brinzolamide—Pruritus—Methylprednisolone—psoriatic arthritis	0.00103	0.00105	CcSEcCtD
Brinzolamide—Dyspepsia—Prednisone—psoriatic arthritis	0.00101	0.00103	CcSEcCtD
Brinzolamide—Myalgia—Methotrexate—psoriatic arthritis	0.001	0.00102	CcSEcCtD
Brinzolamide—Arthralgia—Methotrexate—psoriatic arthritis	0.001	0.00102	CcSEcCtD
Brinzolamide—Chest pain—Methotrexate—psoriatic arthritis	0.001	0.00102	CcSEcCtD
Brinzolamide—Decreased appetite—Prednisone—psoriatic arthritis	0.001	0.00102	CcSEcCtD
Brinzolamide—Rash—Prednisolone—psoriatic arthritis	0.000999	0.00102	CcSEcCtD
Brinzolamide—Dermatitis—Prednisolone—psoriatic arthritis	0.000998	0.00102	CcSEcCtD
Brinzolamide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.000997	0.00102	CcSEcCtD
Brinzolamide—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.000995	0.00101	CcSEcCtD
Brinzolamide—Fatigue—Prednisone—psoriatic arthritis	0.000993	0.00101	CcSEcCtD
Brinzolamide—Headache—Prednisolone—psoriatic arthritis	0.000993	0.00101	CcSEcCtD
Brinzolamide—Discomfort—Methotrexate—psoriatic arthritis	0.000992	0.00101	CcSEcCtD
Brinzolamide—Dizziness—Triamcinolone—psoriatic arthritis	0.000964	0.000983	CcSEcCtD
Brinzolamide—Dizziness—Methylprednisolone—psoriatic arthritis	0.000961	0.000981	CcSEcCtD
Brinzolamide—Infection—Methotrexate—psoriatic arthritis	0.000956	0.000975	CcSEcCtD
Brinzolamide—Feeling abnormal—Prednisone—psoriatic arthritis	0.000949	0.000968	CcSEcCtD
Brinzolamide—Asthenia—Dexamethasone—psoriatic arthritis	0.000949	0.000968	CcSEcCtD
Brinzolamide—Asthenia—Betamethasone—psoriatic arthritis	0.000949	0.000968	CcSEcCtD
Brinzolamide—Nervous system disorder—Methotrexate—psoriatic arthritis	0.000944	0.000963	CcSEcCtD
Brinzolamide—Nausea—Prednisolone—psoriatic arthritis	0.000941	0.00096	CcSEcCtD
Brinzolamide—Pruritus—Betamethasone—psoriatic arthritis	0.000935	0.000954	CcSEcCtD
Brinzolamide—Pruritus—Dexamethasone—psoriatic arthritis	0.000935	0.000954	CcSEcCtD
Brinzolamide—Skin disorder—Methotrexate—psoriatic arthritis	0.000935	0.000954	CcSEcCtD
Brinzolamide—Vomiting—Triamcinolone—psoriatic arthritis	0.000926	0.000945	CcSEcCtD
Brinzolamide—Vomiting—Methylprednisolone—psoriatic arthritis	0.000924	0.000943	CcSEcCtD
Brinzolamide—Rash—Triamcinolone—psoriatic arthritis	0.000919	0.000937	CcSEcCtD
Brinzolamide—Dermatitis—Triamcinolone—psoriatic arthritis	0.000918	0.000936	CcSEcCtD
Brinzolamide—Rash—Methylprednisolone—psoriatic arthritis	0.000917	0.000935	CcSEcCtD
Brinzolamide—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000916	0.000934	CcSEcCtD
Brinzolamide—Urticaria—Prednisone—psoriatic arthritis	0.000915	0.000933	CcSEcCtD
Brinzolamide—Headache—Triamcinolone—psoriatic arthritis	0.000913	0.000931	CcSEcCtD
Brinzolamide—Headache—Methylprednisolone—psoriatic arthritis	0.000911	0.000929	CcSEcCtD
Brinzolamide—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000905	0.000923	CcSEcCtD
Brinzolamide—Diarrhoea—Betamethasone—psoriatic arthritis	0.000905	0.000923	CcSEcCtD
Brinzolamide—Hypotension—Methotrexate—psoriatic arthritis	0.000899	0.000917	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.000877	0.000894	CcSEcCtD
Brinzolamide—Dizziness—Betamethasone—psoriatic arthritis	0.000874	0.000892	CcSEcCtD
Brinzolamide—Dizziness—Dexamethasone—psoriatic arthritis	0.000874	0.000892	CcSEcCtD
Brinzolamide—Insomnia—Methotrexate—psoriatic arthritis	0.00087	0.000888	CcSEcCtD
Brinzolamide—Nausea—Triamcinolone—psoriatic arthritis	0.000866	0.000883	CcSEcCtD
Brinzolamide—Paraesthesia—Methotrexate—psoriatic arthritis	0.000864	0.000881	CcSEcCtD
Brinzolamide—Nausea—Methylprednisolone—psoriatic arthritis	0.000864	0.000881	CcSEcCtD
Brinzolamide—Dyspnoea—Methotrexate—psoriatic arthritis	0.000858	0.000875	CcSEcCtD
Brinzolamide—Somnolence—Methotrexate—psoriatic arthritis	0.000855	0.000873	CcSEcCtD
Brinzolamide—Hypersensitivity—Prednisone—psoriatic arthritis	0.000848	0.000865	CcSEcCtD
Brinzolamide—Dyspepsia—Methotrexate—psoriatic arthritis	0.000847	0.000864	CcSEcCtD
Brinzolamide—Vomiting—Betamethasone—psoriatic arthritis	0.000841	0.000858	CcSEcCtD
Brinzolamide—Vomiting—Dexamethasone—psoriatic arthritis	0.000841	0.000858	CcSEcCtD
Brinzolamide—Decreased appetite—Methotrexate—psoriatic arthritis	0.000837	0.000853	CcSEcCtD
Brinzolamide—Rash—Dexamethasone—psoriatic arthritis	0.000834	0.00085	CcSEcCtD
Brinzolamide—Rash—Betamethasone—psoriatic arthritis	0.000834	0.00085	CcSEcCtD
Brinzolamide—Dermatitis—Dexamethasone—psoriatic arthritis	0.000833	0.00085	CcSEcCtD
Brinzolamide—Dermatitis—Betamethasone—psoriatic arthritis	0.000833	0.00085	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000831	0.000848	CcSEcCtD
Brinzolamide—Fatigue—Methotrexate—psoriatic arthritis	0.00083	0.000846	CcSEcCtD
Brinzolamide—Headache—Dexamethasone—psoriatic arthritis	0.000828	0.000845	CcSEcCtD
Brinzolamide—Headache—Betamethasone—psoriatic arthritis	0.000828	0.000845	CcSEcCtD
Brinzolamide—Asthenia—Prednisone—psoriatic arthritis	0.000826	0.000843	CcSEcCtD
Brinzolamide—Pain—Methotrexate—psoriatic arthritis	0.000823	0.000839	CcSEcCtD
Brinzolamide—Pruritus—Prednisone—psoriatic arthritis	0.000815	0.000831	CcSEcCtD
Brinzolamide—Feeling abnormal—Methotrexate—psoriatic arthritis	0.000793	0.000809	CcSEcCtD
Brinzolamide—Diarrhoea—Prednisone—psoriatic arthritis	0.000788	0.000804	CcSEcCtD
Brinzolamide—Nausea—Dexamethasone—psoriatic arthritis	0.000785	0.000801	CcSEcCtD
Brinzolamide—Nausea—Betamethasone—psoriatic arthritis	0.000785	0.000801	CcSEcCtD
Brinzolamide—Urticaria—Methotrexate—psoriatic arthritis	0.000764	0.00078	CcSEcCtD
Brinzolamide—Dizziness—Prednisone—psoriatic arthritis	0.000761	0.000777	CcSEcCtD
Brinzolamide—Vomiting—Prednisone—psoriatic arthritis	0.000732	0.000747	CcSEcCtD
Brinzolamide—Rash—Prednisone—psoriatic arthritis	0.000726	0.000741	CcSEcCtD
Brinzolamide—Dermatitis—Prednisone—psoriatic arthritis	0.000725	0.00074	CcSEcCtD
Brinzolamide—Headache—Prednisone—psoriatic arthritis	0.000721	0.000736	CcSEcCtD
Brinzolamide—Hypersensitivity—Methotrexate—psoriatic arthritis	0.000709	0.000723	CcSEcCtD
Brinzolamide—Asthenia—Methotrexate—psoriatic arthritis	0.00069	0.000704	CcSEcCtD
Brinzolamide—Nausea—Prednisone—psoriatic arthritis	0.000684	0.000698	CcSEcCtD
Brinzolamide—Pruritus—Methotrexate—psoriatic arthritis	0.000681	0.000695	CcSEcCtD
Brinzolamide—Diarrhoea—Methotrexate—psoriatic arthritis	0.000658	0.000672	CcSEcCtD
Brinzolamide—Dizziness—Methotrexate—psoriatic arthritis	0.000636	0.000649	CcSEcCtD
Brinzolamide—Vomiting—Methotrexate—psoriatic arthritis	0.000612	0.000624	CcSEcCtD
Brinzolamide—Rash—Methotrexate—psoriatic arthritis	0.000607	0.000619	CcSEcCtD
Brinzolamide—Dermatitis—Methotrexate—psoriatic arthritis	0.000606	0.000618	CcSEcCtD
Brinzolamide—Headache—Methotrexate—psoriatic arthritis	0.000603	0.000615	CcSEcCtD
Brinzolamide—Nausea—Methotrexate—psoriatic arthritis	0.000572	0.000583	CcSEcCtD
